Tetra.png

Tetra Bio-Pharma is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a clinical program aimed at bringing novel drugs and treatments to patients and their healthcare providers. 

Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety date require for inclusion into the existing bio pharma industry by regulators, physicians, and insurance companies. 

The Canadian Journal of Medical Cannabis is published by Chronicle Companies

Ideas in the Service of Medicine 

© Chronicle Companies 2020